Six-month interim examination involving continuing immunogenicity monitoring of the mRNA-1273 vaccine within health care personnel: A third measure is predicted.
Six-month interim examination involving continuing immunogenicity monitoring of the mRNA-1273 vaccine within health care personnel: A third measure is predicted.